Original research · Open data
Research
Nobody had enumerated what medicines actually disclose about their starch excipients. These papers do that, at scale, from primary regulatory sources. Every figure is reproducible from published code and every dataset is CC0.
The Vocabulary Beats the Mandate: Starch Source Disclosure in Paired US and EU Drug Labels
A within-molecule comparison of 86 medicines authorised in both markets. US labels name the starch's botanical source for 88.4% of molecules against 38.4% for EU leaflets; all 43 discordant pairs favour the US label (McNemar exact p = 2.3e-13).
Published August 2, 2026 · 1,874 words · 3 data files · Read →
The Source-Disclosure Gap: Starch Excipients in 1,360 EU Centrally-Authorised Medicines
An excipient census of European Medicines Agency product information leaflets. 218 of 1,360 products contain a starch or dextrin excipient; exactly half name no botanical source. No product declares wheat starch.
Published August 2, 2026 · 2,389 words · 3 data files · Read →
Seven Years of Drift: Measuring the Decay of the Reference List Celiac Patients Are Told to Use
A comparison of glutenfreedrugs.com against current US drug labels. 31.6% of drug names fail a direct lookup; the manufacturer named by the list is no longer a current labeler for 67.6% of assessable entries.
Published August 2, 2026 · 1,980 words · 4 data files · Read →
Citing this work
All datasets and code are released CC0. Attribution is not required but is appreciated, and it makes corrections easier to route if a figure is later revised. Preferred form: Walsch N, [title], Gluten Screen, 2026.
Corrections and disputes: see the corrections policy. Substantive corrections are disclosed on the affected paper with a dated note rather than silently edited — one such correction is already annotated on the EU excipient census.